hotspot -WSS

hotspot

author：explore 2025-09-30 17:30:12 - browse：2413

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Plastic surgeons increase patient psychiatric screenings

Wikipedia

entertainment

WSS

Plastic surgeons increase patient psychiatric screenings

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Intermittent fasting comes with a heart risk? Not so fast

Cholera vaccine supplies dangerously low, outbreaks surging

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

hotspot

hotspot

focus

Duchenne breakthrough therapy leaves behind pioneering families

Redefining sustainability for the pharmaceutical industry

Novavax promises a turnaround & Lilly roils the obesity market

Nurses recount patients attacks

In Memoriam: Notable people who died in 2023

Study fuels hope CAR

Walensky prepares to leave CDC — and Congress — behind

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Anesthesiologist group: stop taking Ozempic before surgery

Cholera vaccine supplies dangerously low, outbreaks surging

focus

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Plastic surgeons increase patient psychiatric screenings

Gene editing the human germline: What are the risks?

Readout Newsletter: Bluebird, CVS, Contineum

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

focus

Wikipedia

entertainment

hotspot